Effectiveness of an Extended Release Stimulant Medication in Treating Preschool Children With Attention Deficit Hyperactivity Disorder (The APS Study) - Related Studies

Effectiveness of an Extended Release Stimulant Medication in Treating Preschool Children With Attention Deficit Hyperactivity Disorder (The APS Study)

This study is currently recruiting participants.

Study NCT00712699. Last updated on July 15, 2008. Information provided by National Institute of Mental Health (NIMH)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Additional conditions recognized in this trial
		Attention Deficit Disorder with Hyperactivity
		Disease
		Hyperkinesis

2	More general conditions related to this trial
		Attention Deficit and Disruptive Behavior Disorders
		Dyskinesias
		Mental Disorders
		Mental Disorders Diagnosed in Childhood
		Nervous System Diseases
		Neurologic Manifestations
		Pathologic Processes
		Signs and Symptoms

3	Interventions listed in this trial
		Placebo

4	Additional drug interventions recognized in this trial
		Amphetamine

5	More general drug interventions related to this trial
		Adrenergic Agents
		Adrenergic Uptake Inhibitors
		Autonomic Agents
		Central Nervous System Agents
		Central Nervous System Stimulants
		Dopamine Agents
		Dopamine Uptake Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Neurotransmitter Agents
		Neurotransmitter Uptake Inhibitors
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Sympathomimetics
		Therapeutic Uses

6	Sponsors listed in this trial
		National Institute of Mental Health (NIMH)